Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma

Clinical trial NCT02268045 · COMPLETED

Trial details

NCT number: NCT02268045
Sponsor: mAbxience Research S.L.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma

Start date: 2013-05-01
Primary completion: 2016-05-01
Enrollment: 272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.